Tilray Brands, Inc. (TLRY)


-0.17 (-6.61%)
Symbol TLRY
Price $2.4
Beta 2.519
Volume Avg. 31.60M
Market Cap 1.688B
Shares () -
52 Week Range 1.5-5.12
1y Target Est -
DCF Unlevered TLRY DCF ->
DCF Levered TLRY LDCF ->
ROE -36.73% Strong Sell
ROA -33.50% Strong Sell
Operating Margin -
Debt / Equity 17.80% Neutral
P/E -1.08 Sell
P/B 0.44 Neutral


Consensus EPS

Upgrades & Downgrades

Latest TLRY news

Mr. Irwin David Simon
Drug Manufacturers—Specialty & Generic
NASDAQ Global Select

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.